Background: Exertional dyspnea is the primary symptom that limits exercise in patients with chronic obstructive pulmonary disease (COPD). It is unknown which activated brain area is associated with this symptom in COPD patients. Objectives: To investigate the activation of cortical areas associated with dyspnea during exercise in COPD patients. Methods: COPD patients (n = 10) and age-matched controls (n = 10) performed mild-intensity constant work rate cycle exercise (40% of their symptom-limited peak work rates) for 10 min, while cerebral hemodynamics and oxygenation were measured by near-infrared spectroscopy (NIRS). Ventilatory responses (breathing pattern and pulmonary gas exchange) and Borg scale ratings of dyspnea and leg fatigue were measured during exercise. Three NIRS probes were placed over the prefrontal and temporoparietal cortical regions of the subjects’ heads. Changes in cortical oxyhemoglobin (oxy-Hb), deoxyhemoglobin (deoxy-Hb), and total hemoglobin (total Hb) concentrations from baseline recordings were measured. Increased oxy-Hb (oxygenation) was assumed to reflect cortical activation. Results: Oxy-Hb concentration was significantly increased in the prefrontal region during exercise in both groups but not in the temporoparietal regions. The change in prefrontal oxy-Hb concentration of COPD patients was not different from that of controls. Dyspnea scores were positively correlated with changes in oxy-Hb concentrations of the prefrontal regions in both groups. Multivariate analysis showed that oxy-Hb concentration in the prefrontal region was the best predictor of dyspnea in both groups. Conclusions: Exertional dyspnea was related to activation (oxygenation) of the prefrontal cortex in COPD patients and control subjects.

Keywords:
Chronic obstructive pulmonary disease, Dyspnea, Exercise, Near-infrared spectroscopy
1.
Sterman DH, Mehta AC, Wood DE, Mathur PN, McKenna RJ, Jr., Ost DE, Truwit JD, Diaz P, Wahidi MM, Cerfolio R, Maxfield R, Musani AI, Gildea T, Sheski F, Machuzak M, Haas AR, Gonzalez HX, Springmeyer SC: A multicenter pilot study of a bronchial valve for the treatment of severe emphysema. Respiration 2010;79:222–233.
2.
Dyspnea. Mechanisms, assessment, and management: a consensus statement. American Thoracic Society. Am J Respir Crit Care Med 1999;159:321–340.
3.
Borg GA: Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982;14:377–381.
4.
O’Donnell DE, Lam M, Webb KA: Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158:1557–1565.
5.
O’Donnell DE, Hamilton AL, Webb KA: Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD. J Appl Physiol 2006;101:1025–1035.
6.
Evans KC, Banzett RB, Adams L, McKay L, Frackowiak RS, Corfield DR: BOLD fMRI identifies limbic, paralimbic, and cerebellar activation during air hunger. J Neurophysiol 2002;88:1500–1511.
7.
von Leupoldt A, Sommer T, Kegat S, Baumann HJ, Klose H, Dahme B, Buchel C: The unpleasantness of perceived dyspnea is processed in the anterior insula and amygdala. Am J Respir Crit Care Med 2008;177:1026–1032.
8.
Perrey S: Non-invasive NIR spectroscopy of human brain function during exercise. Methods 2008;45:289–299.
9.
Taga G, Asakawa K, Maki A, Konishi Y, Koizumi H: Brain imaging in awake infants by near-infrared optical topography. Proc Natl Acad Sci USA 2003;100:10722–10727.
10.
Gervain J, Macagno F, Cogoi S, Pena M, Mehler J: The neonate brain detects speech structure. Proc Natl Acad Sci USA 2008;105:14222–14227.
11.
Ide K, Secher NH: Cerebral blood flow and metabolism during exercise. Prog Neurobiol 2000;61:397–414.
12.
Mihara M, Miyai I, Hatakenaka M, Kubota K, Sakoda S: Sustained prefrontal activation during ataxic gait: a compensatory mechanism for ataxic stroke? Neuroimage 2007;37:1338–1345.
13.
Mihara M, Miyai I, Hatakenaka M, Kubota K, Sakoda S: Role of the prefrontal cortex in human balance control. Neuroimage 2008;43:329–336.
14.
Kobayashi E, Kusaka T, Karaki M, Kobayashi R, Itoh S, Mori N: Functional optical hemodynamic imaging of the olfactory cortex. Laryngoscope 2007;117:541–546.
15.
Lee J, Folley BS, Gore J, Park S: Origins of spatial working memory deficits in schizophrenia: an event-related fMRI and near-infrared spectroscopy study. PLoS One 2008;3:e1760.
16.
Okamoto M, Dan I: Automated cortical projection of head-surface locations for transcranial functional brain mapping. Neuroimage 2005;26:18–28.
17.
Villringer A, Chance B: Non-invasive optical spectroscopy and imaging of human brain function. Trends Neurosci 1997;20:435–442.
18.
Pena M, Maki A, Kovacic D, Dehaene-Lambertz G, Koizumi H, Bouquet F, Mehler J: Sounds and silence: an optical topography study of language recognition at birth. Proc Natl Acad Sci USA 2003;100:11702–11705.
19.
Okamoto M, Dan H, Sakamoto K, Takeo K, Shimizu K, Kohno S, Oda I, Isobe S, Suzuki T, Kohyama K, Dan I: Three-dimensional probabilistic anatomical cranio-cerebral correlation via the international 10–20 system oriented for transcranial functional brain mapping. Neuroimage 2004;21:99–111.
20.
Shibuya K, Ueda C, Sato K, Shimizu-Okuyama S, Saito M, Kagaya A, Kamo M, Osada T, Sadamoto T: Perceived exertion is not necessarily associated with altered brain activity during exercise. J Physiol Anthropol 2009;28:63–69.
21.
Ide K, Horn A, Secher NH: Cerebral metabolic response to submaximal exercise. J Appl Physiol 1999;87:1604–1608.
22.
Puente-Maestu L, Garcia de Pedro J, Martinez-Abad Y, Ruiz de Ona JM, Llorente D, Cubillo JM: Dyspnea, ventilatory pattern, and changes in dynamic hyperinflation related to the intensity of constant work rate exercise in COPD. Chest 2005;128:651–656.
23.
Subudhi AW, Dimmen AC, Roach RC: Effects of acute hypoxia on cerebral and muscle oxygenation during incremental exercise. J Appl Physiol 2007;103:177–183.
24.
Subudhi AW, Miramon BR, Granger ME, Roach RC: Frontal and motor cortex oxygenation during maximal exercise in normoxia and hypoxia. J Appl Physiol 2009;106:1153–1158.
25.
Jensen G, Nielsen HB, Ide K, Madsen PL, Svendsen LB, Svendsen UG, Secher NH: Cerebral oxygenation during exercise in patients with terminal lung disease. Chest 2002;122:445–450.
26.
von Leupoldt A, Dahme B: Cortical substrates for the perception of dyspnea. Chest 2005;128:345–354.
27.
Nybo L, Nielsen B: Perceived exertion is associated with an altered brain activity during exercise with progressive hyperthermia. J Appl Physiol 2001;91:2017–2023.
28.
Nielsen HB, Boesen M, Secher NH: Near-infrared spectroscopy determined brain and muscle oxygenation during exercise with normal and resistive breathing. Acta Physiol Scand 2001;171:63–70.
29.
Madsen PL, Sperling BK, Warming T, Schmidt JF, Secher NH, Wildschiodtz G, Holm S, Lassen NA: Middle cerebral artery blood velocity and cerebral blood flow and O2 uptake during dynamic exercise. J Appl Physiol 1993;74:245–250.
30.
O’Donnell DE, Banzett RB, Carrieri-Kohlman V, Casaburi R, Davenport PW, Gandevia SC, Gelb AF, Mahler DA, Webb KA: Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable. Proc Am Thorac Soc 2007;4:145–168.
31.
Schon D, Dahme B, von Leupoldt A: Associations between the perception of dyspnea, pain, and negative affect. Psychophysiology 2008;45:1064–1067.
32.
von Leupoldt A, Ambruzsova R, Nordmeyer S, Jeske N, Dahme B: Sensory and affective aspects of dyspnea contribute differentially to the Borg scale’s measurement of dyspnea. Respiration 2006;73:762–768.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.